Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | TABLET | Resolved | 2019-10-31 | 2020-05-01 | 97622 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2021-01-15 | 2021-02-05 | 131700 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 10MG | TABLET | Resolved | 2023-07-18 | 2023-10-03 | 199103 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 25MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124983 |
| TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42594 |
| TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42591 |
| TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2023-07-18 | 2023-07-21 | 198957 |
| TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2022-07-25 | 2022-10-01 | 165441 |
| TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118925 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113752 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1026 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113770 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-03-26 | 2020-05-14 | 109580 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-07-27 | 2292 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114430 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-09-17 | 2020-11-19 | 124480 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114433 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163918 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |
| TEVA-TENOFOVIR | 300MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256088 |
| TEVA-TOPISONE | 0.05% | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231589 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256104 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |